An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Journal article

Open access

Peer reviewed

Julien Péron, Pascal Roy, T. Conroy, Françoise Desseigne, M. Ychou, S. Gourgou-Bourgade, T. Stanbury, L. Roche, B. Ozenne and M. Buyse

Oncotarget, Vol.7, pp.82953-28960

2016

PMCID: PMC5347744

Files and links (2)

url

Find in HALView

url

https://doi.org/10.18632/oncotarget.12761View

Published (Version of record) Open

1 Record Views

Title: An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
Creators - without role: Julien Péron - Hospices Civils de Lyon
Pascal Roy - Hôpital Lyon Sud
T. Conroy - Institut de Cancérologie de Lorraine
Françoise Desseigne - Centre Léon Bérard
M. Ychou - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCM
S. Gourgou-Bourgade - Institut Regional du Cancer de Montpellier
T. Stanbury - UniCancer Group
L. Roche - Laboratoire de Biométrie et Biologie Evolutive
B. Ozenne - Laboratoire de Biométrie et Biologie Evolutive
M. Buyse
Publication Details: Oncotarget, Vol.7, pp.82953-28960
Identifiers: 9937846809311
Academic Unit: Institut de Recherche en Cancérologie de Montpellier - IRCM
Language: English
Resource Type: Journal article
Local Fields: hal-02053624